Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115088
Chunk: 373

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 373
---
 at which it may first be exercised or the time during which it will vest. The Committee will have the authority to amend, suspend, or terminate the Inducement Plan at any time, provided that such action does not materially impair the existing rights of any participant without such participant’s written consent. No awards may be granted under the Inducement Plan while it is suspended or after it is terminated.

Emerging Growth Company Status

We are an “emerging growth company” as defined in the JOBS Act. As an emerging growth company, we are exempted from certain requirements related to executive compensation, including the requirements to hold a nonbinding advisory vote on executive compensation and to provide information relating to the ratio of total compensation of our Chief Executive Officer to the median of the annual total compensation of all of our employees, each as required by the Investor Protection and Securities Reform Act of 2010, which is part of the Dodd-Frank Act.**

<div align='center'>237</div>

Director Compensation The following table provides information regarding the total compensation that was earned by or paid to each of our non-employeedirectors during the year ended December 31, 2024.

| Name(1)                        
 Current Non-Employee Directors |     | Fees Earned 
 or Paid in  
 Cash ($)    |         |     | Option        
 Awards ($)(2) |         |     | All Other        
 Compensation ($) |   |     | Total ($) |         |
|:-------------------------------|:----|:------------|--------:|:----|:--------------|--------:|:----|:-----------------|:--|:----|:----------|--------:|
| Jay Chun, M.D., Ph.D.          |     | $           |  73,125 |     | $             |  42,770 |     |                  | — |     | $         | 115,895 |
| Dorman Followwill              |     | $           | 170,545 |     | $             | 131,400 |     |                  | — |     | $         | 301,945 |
| Yue Alexander Wu, Ph.D.        |     | $           | 127,500 |     | $             |  42,770 |     |                  | — |     | $         | 170,270 |
| Annu Navani, M.D.(3)           |     | $           |       — |     | $             | 239,225 |     |